What is the optimal vitamin D level for health?

Therapy

Volumn 5, Issue 5, 2008, Pages 655-658

  Giovannucci, Edward ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; COLECALCIFEROL; PHOSPHORUS; VITAMIN D;

AUTOIMMUNE DISEASE; CALCIUM HOMEOSTASIS; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DIETARY INTAKE; EDITORIAL; FRACTURE; HUMAN; IMMUNE RESPONSE; INFECTION; MALIGNANT NEOPLASTIC DISEASE; METABOLISM; NONHUMAN; NUTRITIONAL HEALTH; OSTEOMALACIA; OSTEOPOROSIS; PHOSPHATE METABOLISM; SUN EXPOSURE; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

EID: 64849115311     PISSN: 14750708     EISSN: 1744831X     Source Type: Journal    
DOI: 10.2217/14750708.5.5.655     Document Type: Editorial

References (30)

1. Heaney RP: Functional indices of vitamin D status and ramifications of vitamin D deficiency. Am. J. Clin. Nutr. 80(6 Suppl.), S1706-S1709 (2004).
2. Bischoff-Ferrari HA, Willett WC, Wong JB et al.: Fracture preventive with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 293(18), 2257-2264 (2005).
3. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B: Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am. J. Clin. Nutr. 84(1), 18-28 (2006).
4. Ruohola JP, Laaksi I, Ylikomi T et al.: Association between serum 25 (OH) D concentrations and bone stress fractures in Finnish young men. J. Bone Miner. Res. 21(9), 1483-1488 (2006).
5. Lappe J, Cullen D, Haynatzki G et al.: Calcium and vitamin D supplementation decreases incidence of stress fractures in female navy recruits. J. Bone. Miner. Res. 23(5), 741-749 (2008).
6. Adorini L, Penna G: Control of autoimmune diseases by the vitamin D endocrine system. Nat. Clin. Pract. Rheumatol. 4(8), 404-412 (2008).
7. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A: Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 296(23), 2832-2838 (2006).
8. Hypponen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM: Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 358(9292), 1500-1503 (2001).
9. Zasloff M: Fighting infections with vitamin D. Nat. Med. 12(4), 388-390 (2006).
10. Liu PT, Stenger S, Li H et al.: Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311(5768), 1770-1773 (2006).
11. Cannell JJ, Vieth R, Umhau JC et al.: Epidemic influenza and vitamin D. Epidemiol. Infect. 134(6), 1129-1140 (2006).
12. Aloia JF, Li-Ng M: Re: Epidemic influenza and vitamin D. Epidemiol. Infect. 135(7), 1095-1096 (2007).
13. Zittermann A, Schleithoff SS, Koerfer R: Putting cardiovascular disease and vitamin D insufficiency into perspective. Br. J. Nutr. 94(4), 483-492 (2005).
14. Wang TJ, Pencina MJ, Booth SL et al.: Vitamin D deficiency and risk of cardiovascular disease. Circulation 117(4), 503-511 (2008).
15. Giovannucci E, Liu Y, Hollis BW, Rimm EB: 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch. Intern. Med. 168(11), 1174-1180 (2008).
16. Dobnig H, Pilz S, Scharnagl H et al.: Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch. Intern. Med. 168(12), 1340-1349 (2008).
17. Pilz S, Dobnig H, Fischer JE et al.: Low vitamin D levels predict stroke in patients referred to coronary angiography. Stroke 39(9), 2611-213 (2008).
18. Autier P, Gandini S: Vitamin D supplements and total mortality: a meta-analysis of randomised controlled trials. Arch. Intern. Med. 167(16), 1730-1737 (2007).
19. Giovannucci E: The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control 16(2), 83-95 (2005).
20. Gorham ED, Garland CF, Garland FC et al.: Optimal vitamin D status for colorectal cancer prevention. A quantitative meta analysis. Am. J, Prev. Med. 32(3), 210-216 (2007).
21. Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Haeney RP: Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am. J. Clin. Nutr. 85(6), 1586-1591 (2007).
22. Wactawski-Wendel J, Kotchen JM, Anderson GL et al.: Calcium plus vitamin D supplementation and the risk of colorectal cancer. N. Engl. J. Med. 354(7), 684-696 (2006).
23. Zhou W, Heist RS, Liu G et al.: Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients. J. Clin. Oncol. 25(5), 479-485 (2007).
24. Ng K, Meyerhardt JA, Wu K et al.: Circulating 25-hydroxyvitamin D levels and survival in patients with colorectal cancer. J. Clin. Oncol. 26(18), 2984-2991 (2008).
25. Nurnberg B, Schadendorf D, Gartner B et al.: Progression of malignant melanoma is associated with reduced 25-hydroxyvitamin D serum levels. Exp. Dermatol. 17(7), 627 (2008).
26. Holick MF: Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am. J. Clin. Nutr. 80(6 Suppl.), S1678-S1688 (2004).
27. Vieth R, Bischoff-Ferrari H, Boucher BJ et al.: The urgent need to recommend an intake of vitamin D that is effective. Am. J. Clin. Nutr. 85(3), 649-650 (2007).
28. Vieth R: Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am. J. Clin. Nutr. 69(5), 842-856 (1999).
29. Hathcock JN, Shao A, Vieth R, Heaney R: Risk assessment for vitamin D. Am. J. Clin. Nutr. 85(1), 6-18 (2007).
30. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ: Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am. J. Clin. Nutr. 77, 204-210 (2003).